About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 6598 record(s)
Req # A-2024-000787
Adverse Drug Reactions (ADRs) for Mesalazine. Report numbers: E2B_07270577, E2B_07290183, E2B_07292296, 001102535, E2B_07290569, E2B_07315569, E2B_07285367. ADRs for Mesalamine. Report numbers: E2B_07276842, E2B_07305609, E2B_07289987.Organization: Health Canada
January 2025
Req # A-2024-000791
Adverse Drug Reaction (ADR) for Ondansetron. Report number: E2B_07292203.Organization: Health Canada
January 2025
Req # A-2024-000797
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 24-107366-571, Third Legislative Review of the Tobacco and Vaping Products Act.Organization: Health Canada
January 2025
Req # A-2024-000821
Adverse Drug Reactions (ADRs). Report numbers: 01087705, 01090547, E2B_07139768, E2B_07137470, E2B_07151229, 1087260, E2B_07181867, E2B_07184102, E2B_07184438, E2B_07184444.Organization: Health Canada
January 2025
Req # A-2024-000843
Adverse Drug Reaction (ADR). Report number: E2B_00071289.Organization: Health Canada
January 2025
Req # A-2024-000848
Adverse Drug Reactions (ADRs). Report numbers: E2B_05006851, 001085629, 001085797, 001081844, E2B_07068557.Organization: Health Canada
January 2025
Req # A-2024-000851
Adverse Drug Reactions (ADRs). Report numbers: E2B_07201886, E2B_07201898, E2B_07201903, E2B_07214924, E2B_07215495, E2B_07236001.Organization: Health Canada
January 2025
Req # A-2024-000863
Adverse Drug Reaction (ADR). Report number: E2B_03172074.Organization: Health Canada
January 2025
Req # A-2024-000865
Adverse Drug Reactions (ADRs). Report numbers: E2B_07298827, E2B_07312723, E2B_07246122, 001103895.Organization: Health Canada
January 2025
Req # A-2024-000867
Adverse Drug Reactions (ADRs). Report numbers: 001095724, 001098124, E2B_07242349, 001102166, E2B_07271117.Organization: Health Canada
January 2025